Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ejphar.2020.173629 http://scihub22266oqcxt.onion/10.1016/j.ejphar.2020.173629 33022271!7832208!33022271     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33022271&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Eur+J+Pharmacol 2020 ; 889 (?): 173629 Nephropedia Template TP {{tp|p=33022271|t=2020. Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19?|pdf=|usr=}}{{33022271}} gab.com Text Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19 JO: Eur J Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=33022271 #FOAvip The absence of a specific treatment for SARS-CoV-2 infection led to an intense global effort in order to find new therapeutic interventions and improve patient outcomes. One important feature of COVID-19 pathophysiology is the activation of immune cells, with consequent massive production and release of inflammatory mediators that may cause impairment of several organ functions, including the brain. In addition to its classical role as a neurotransmitter, serotonin (5-hydroxytryptamine, 5-HT) has immunomodulatory properties, downregulating the inflammatory response by central and peripheral mechanisms. In this review, we describe the roles of 5-HT in the regulation of systemic inflammation and the potential benefits of the use of specific serotonin reuptake inhibitors as a coadjutant therapy to attenuate neurological complications of COVID-19. Twit Text FOAVip Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19 ????Eur J Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=33022271 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33022271 #FOAvip English Wikipedia <ref>{{Cite pmid|33022271}}</ref> Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19? #MMPMID33022271 Costa LHA; Santos BM; Branco LGS Eur J Pharmacol 2020[Dec]; 889 (?): 173629 PMID33022271show ga The absence of a specific treatment for SARS-CoV-2 infection led to an intense global effort in order to find new therapeutic interventions and improve patient outcomes. One important feature of COVID-19 pathophysiology is the activation of immune cells, with consequent massive production and release of inflammatory mediators that may cause impairment of several organ functions, including the brain. In addition to its classical role as a neurotransmitter, serotonin (5-hydroxytryptamine, 5-HT) has immunomodulatory properties, downregulating the inflammatory response by central and peripheral mechanisms. In this review, we describe the roles of 5-HT in the regulation of systemic inflammation and the potential benefits of the use of specific serotonin reuptake inhibitors as a coadjutant therapy to attenuate neurological complications of COVID-19. |*COVID-19 Drug Treatment[MESH] |Animals[MESH] |COVID-19/complications[MESH] |Humans[MESH] |Inflammation/complications/*drug therapy[MESH] |Nervous System Diseases/complications/*drug therapy[MESH] |Neuroprotective Agents/pharmacology/*therapeutic use[MESH] |Pandemics[MESH] |SARS-CoV-2[MESH]Can selective serotonin reuptake inhibitors have a neuroprotective eff(epmc).pdf DeepDyve Pubget Overpricing